Neurofilament light chain predicts disease activity in relapsing-remitting MS.

about

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

Item

http://www.wikidata.org/entity/Q47138197

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

@en

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

@nl

type

Item

label

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

@en

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

@nl

prefLabel

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

@en

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

@nl

P1476

Neurofilament light chain predicts disease activity in relapsing-remitting MS

@en

P2093

Christian Vedeler

http://www.w3.org/2001/XMLSchema#string

Jens Kuhle

http://www.w3.org/2001/XMLSchema#string

Kjell-Morten Myhr

http://www.w3.org/2001/XMLSchema#string

Kristin N Varhaug

http://www.w3.org/2001/XMLSchema#string

Stig Wergeland

http://www.w3.org/2001/XMLSchema#string

P2860

Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis

Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis

Axonal transection in the lesions of multiple sclerosis

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.

Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

P304

e422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/NXI.0000000000000422

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29209636

http://www.w3.org/2001/XMLSchema#string

P932

5707445

http://www.w3.org/2001/XMLSchema#string